Radiopharmaceuticals

"Radiopharmaceuticals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Descriptor ID	D019275
MeSH Number(s)	D27.505.259.843 D27.505.519.871 D27.720.470.410.650
Concept/Terms	Radiopharmaceuticals Radiopharmaceuticals

Below are MeSH descriptors whose meaning is more general than "Radiopharmaceuticals".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Diagnostic Uses of Chemicals [D27.505.259]
Radiopharmaceuticals [D27.505.259.843]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Radiopharmaceuticals [D27.505.519.871]
Specialty Uses of Chemicals [D27.720]
Laboratory Chemicals [D27.720.470]
Indicators and Reagents [D27.720.470.410]
Radiopharmaceuticals [D27.720.470.410.650]

Below are MeSH descriptors whose meaning is related to "Radiopharmaceuticals".

Below are MeSH descriptors whose meaning is more specific than "Radiopharmaceuticals".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Radiopharmaceuticals" by people in this website by year, and whether "Radiopharmaceuticals" was a major or minor topic of these publications.

Bar chart showing 60 publications over 24 distinct years, with a maximum of 7 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
1999	1	0	1
2000	1	0	1
2002	1	0	1
2003	1	2	3
2004	1	4	5
2005	3	2	5
2006	3	3	6
2007	5	2	7
2008	0	3	3
2009	1	1	2
2010	3	0	3
2011	0	1	1
2012	1	2	3
2013	0	2	2
2014	2	1	3
2015	1	0	1
2016	3	1	4
2018	1	1	2
2019	2	0	2
2020	1	0	1
2021	1	0	1
2023	1	0	1
2025	0	1	1

Below are the most recent publications written about "Radiopharmaceuticals" by people in Profiles.

Venables M, Taylor A, Murdoch J, De Sousa JL, Keen H. Use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosing giant cell arteritis in a Western Australian tertiary centre: a 36-month analysis. Intern Med J. 2025 08; 55(8):1308-1315.

View in: PubMed
Phipps MD, Cingoranelli S, Bhupathiraju NVSDK, Younes A, Cao M, Sanders VA, Neary MC, Devany MH, Cutler CS, Lopez GE, Saini S, Parker CC, Fernandez SR, Lewis JS, Lapi SE, Francesconi LC, Deri MA. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals. Inorg Chem. 2023 Dec 18; 62(50):20567-20581.

View in: PubMed
Nautiyal A, Mondal T, Mitra D, Goel A, Dey SK, Kaushik A. A SIMPLE AND NOVEL APPROACH TO STUDY KINETICS AND ESTIMATE RADIATION DOSES FROM INTERNALLY ADMINISTERED RADIOPHARMACEUTICALS USING AN EXTERNAL DOSE MEASUREMENT SYSTEM. Radiat Prot Dosimetry. 2021 Nov 12; 196(3-4):141-152.

View in: PubMed
Lopes NB, Almeida IV, Lopes PHS, Vicentini VEP. Radioprotective efficacy of plastic polymer against the toxicogenomic effects of radiopharmaceutical 18F-FDG on human lymphocytes. Radiat Oncol. 2020 Jun 17; 15(1):154.

View in: PubMed
Mondal T, Nautiyal A, Agrawal M, Mitra D, Goel A, Kumar Dey S. 18F-FDG-induced DNA damage, chromosomal aberrations, and toxicity in V79 lung fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov; 847:503105.

View in: PubMed
MacPherson DS, Fung K, Cook BE, Francesconi LC, Zeglis BM. A brief overview of metal complexes as nuclear imaging agents. Dalton Trans. 2019 Oct 07; 48(39):14547-14565.

View in: PubMed
Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, Prce I, Wilson AA, Rusjan PM, Sailasuta N, Mizrahi R. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study. Neuropsychopharmacology. 2018 07; 43(8):1700-1705.

View in: PubMed
Kwee SA, Wong L, Chan OTM, Kalathil S, Tsai N. PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology. 2018 04; 287(1):294-302.

View in: PubMed
Padia SA, Lewandowski RJ, Johnson GE, Sze DY, Ward TJ, Gaba RC, Baerlocher MO, Gates VL, Riaz A, Brown DB, Siddiqi NH, Walker TG, Silberzweig JE, Mitchell JW, Nikolic B, Salem R. Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions. J Vasc Interv Radiol. 2017 Jan; 28(1):1-15.

View in: PubMed
McDonald JE, Kessler MM, Gardner MW, Buros AF, Ntambi JA, Waheed S, van Rhee F, Zangari M, Heuck CJ, Petty N, Schinke C, Thanendrarajan S, Mitchell A, Hoering A, Barlogie B, Morgan GJ, Davies FE. Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma. Clin Cancer Res. 2017 04 15; 23(8):1981-1987.

View in: PubMed

People

Explore

Similar Concepts

Top Journals